Early research (Phase 1)Ended earlyNCT01278849
What this trial is testing
An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function
Who this might be right for
Histologically-proven and Radiologically-confirmed Solid Tumors
Novartis Pharmaceuticals 5